Application 211939
- Type
- NDA
- Sponsor
- ALVOGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BONSITY | TERIPARATIDE | SOLUTION;SUBCUTANEOUS | 0.62MG/2.48ML (0.25MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N211939-001 | BONSITY | TERIPARATIDE | 0.56MG/2.24ML (0.25MG/ML) | SOLUTION / SUBCUTANEOUS | 2019-10-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | N211939-001 | BONSITY | 0.62MG/2.48ML (0.25MG/ML) | SOLUTION / SUBCUTANEOUS | 2019-10-04 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N211939-001 | BONSITY | 0.62MG/2.48ML (0.25MG/ML) | SOLUTION / SUBCUTANEOUS | 2019-10-04 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N211939-001 | BONSITY | 0.56MG/2.24ML (0.25MG/ML) | SOLUTION / SUBCUTANEOUS | 2019-10-04 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| teriparatide | TERIPARATIDE | Alvogen, Inc. | 1b007339-dd0d-f019-5e0a-9b1b0f75011c | 2026-08-31 | Warnings, Adverse reactions | 211939 NDA211939 47781-652 |
| Bonsity | TERIPARATIDE | Alvogen Inc. | 2d0c89a2-3849-adf6-007d-aeca21cf417c | 2026-08-31 | Warnings, Adverse reactions | 211939 NDA211939 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-652 | teriparatide | teriparatide | Alvogen, Inc. | NDA | Current |
| 47781-652 | teriparatide | teriparatide | Alvogen, Inc. | NDA | Current |
| 47781-652 | teriparatide | teriparatide | Alvogen, Inc. | NDA | Current |
| 47781-652 | teriparatide | teriparatide | Alvogen, Inc. | NDA | Current |
| 47781-652 | teriparatide | teriparatide | Alvogen, Inc. | NDA | Current |